These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36812307)

  • 1. PI3-kinase deletion promotes myelodysplasia by dysregulating autophagy in hematopoietic stem cells.
    Ames K; Kaur I; Shi Y; Tong MM; Sinclair T; Hemmati S; Glushakow-Smith SG; Tein E; Gurska L; Steidl U; Dubin R; Shan J; Montagna C; Pradhan K; Verma A; Gritsman K
    Sci Adv; 2023 Feb; 9(8):eade8222. PubMed ID: 36812307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the Link between Class 1A PI3-Kinase, Autophagy, and Myelodysplasia.
    Ames K; Gritsman K
    Autophagy; 2024 Apr; 20(4):952-954. PubMed ID: 37289024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin induces autophagy in myelodysplastic bone marrow including hematopoietic stem/progenitor compartment.
    Daw S; Law S
    Environ Toxicol; 2021 Feb; 36(2):149-167. PubMed ID: 32902906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.
    Falconi G; Fabiani E; Fianchi L; Criscuolo M; Raffaelli CS; Bellesi S; Hohaus S; Voso MT; D'Alò F; Leone G
    Exp Hematol; 2016 Jan; 44(1):75-83.e1-4. PubMed ID: 26521017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion.
    Perry JM; He XC; Sugimura R; Grindley JC; Haug JS; Ding S; Li L
    Genes Dev; 2011 Sep; 25(18):1928-42. PubMed ID: 21890648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS.
    An N; Khan S; Imgruet MK; Gurbuxani SK; Konecki SN; Burgess MR; McNerney ME
    Blood; 2018 Jun; 131(24):2682-2697. PubMed ID: 29592892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phagocytosis checkpoints on hematopoietic stem cells in patients with myelodysplastic syndromes.
    Dong X; Han Y; Liu Y; Yang L; Niu H; Yan L; Liu C; Shao Z; Xing L; Wang H
    Asia Pac J Clin Oncol; 2022 Apr; 18(2):e119-e128. PubMed ID: 34152084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression.
    Magee JA; Ikenoue T; Nakada D; Lee JY; Guan KL; Morrison SJ
    Cell Stem Cell; 2012 Sep; 11(3):415-28. PubMed ID: 22958933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEK/ERK and PI3K/AKT pathway inhibitors affect the transformation of myelodysplastic syndrome into acute myeloid leukemia via H3K27me3 methylases and de‑methylases.
    Zheng Z; Chen X; Zhang Y; Ren F; Ma Y
    Int J Oncol; 2023 Dec; 63(6):. PubMed ID: 37921060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
    Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
    Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in MDS/AML and inositide signalling.
    De Stefano A; Marvi MV; Fazio A; McCubrey JA; Suh PG; Ratti S; Ramazzotti G; Manzoli L; Cocco L; Follo MY
    Adv Biol Regul; 2023 Jan; 87():100955. PubMed ID: 36706610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atp8a1 deletion increases the proliferative activity of hematopoietic stem cells by impairing PTEN function.
    Zheng L; Pan C; Tian W; Liang C; Feng Y; He W; Yang Z; Wang B; Qiu Q; Li N; Sun Y; Qiu H; Sample KM; Zhou L; Zhu X; Hu Y
    Cell Oncol (Dordr); 2023 Aug; 46(4):1069-1083. PubMed ID: 36930333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Ripk1-mediated bone marrow necroptosis leads to myelodysplasia and bone marrow failure in mice.
    Wagner PN; Shi Q; Salisbury-Ruf CT; Zou J; Savona MR; Fedoriw Y; Zinkel SS
    Blood; 2019 Jan; 133(2):107-120. PubMed ID: 30413413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks.
    Sundaravel S; Kuo WL; Jeong JJ; Choudhary GS; Gordon-Mitchell S; Liu H; Bhagat TD; McGraw KL; Gurbuxani S; List AF; Verma A; Wickrema A
    Clin Cancer Res; 2019 Sep; 25(18):5638-5649. PubMed ID: 31308061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway.
    Roversi FM; Pericole FV; Machado-Neto JA; da Silva Santos Duarte A; Longhini AL; Corrocher FA; Palodetto B; Ferro KP; Rosa RG; Baratti MO; Verjovski-Almeida S; Traina F; Molinari A; Botta M; Saad ST
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):450-461. PubMed ID: 27840303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
    Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM
    Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome.
    Bereshchenko O; Lo Re O; Nikulenkov F; Flamini S; Kotaskova J; Mazza T; Le Pannérer MM; Buschbeck M; Giallongo C; Palumbo G; Li Volti G; Pazienza V; Cervinek L; Riccardi C; Krejci L; Pospisilova S; Stewart AF; Vinciguerra M
    Clin Epigenetics; 2019 Aug; 11(1):121. PubMed ID: 31439048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive MAP kinase activation in hematopoietic stem cells induces a myeloproliferative disorder.
    Chung E; Hsu CL; Kondo M
    PLoS One; 2011; 6(12):e28350. PubMed ID: 22164275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of aberrant hematopoietic and stromal elements in myelodysplastic syndromes.
    Abbas S; Kini A; Srivastava VM; M MT; Nair SC; Abraham A; Mathews V; George B; Kumar S; Venkatraman A; Srivastava A
    Blood Cells Mol Dis; 2017 Jul; 66():37-46. PubMed ID: 28822917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice.
    An N; Kraft AS; Kang Y
    J Hematol Oncol; 2013 Jan; 6():12. PubMed ID: 23360755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.